As APM and β2M are necessary to generate stable MHC-I:peptide complex, introducing TAP1 and β2M genes using recombinant viral vectors was shown to restore surface MHC-I expression and elicit antitumor response in experimental tumor models [221,222,223,224]. The gene discussed is ANPEP; the disease is neoplasm.